AAD 2024: Lutikizumab Promising for Patients With Hard-to-Treat Hidradenitis Suppurativa
Those who previously failed anti-TNF therapy experienced reductions in total abscess and inflammatory nodule count, as well as reductions in skin pain scores
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.